OTD provides independent consulting services in oncology early drug development.
We offer integrated drug discovery services and routinely conduct contract preclinical research.
The OTD team has collective experience managing over 50 Phase I-II oncology clinical trials.
OTD is a CRO focused solely on Oncology.
We are prepared to share our experience and support you in the development of studies that generate data in a timely, efficient and cost-effective manner.
Fsn0503h antibody-mediated blockade of cathepsin S as a therapeutic strategy for the treatment of solid tumors.
100 rue Martre
92110 Clichy - FRANCE
Tel: +33 1 47 15 01 01
Fax: +33 1 45 19 06 59